Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis.

Scientific Reports
Chen-Hua LiuJia-Horng Kao

Abstract

Data regarding the efficacy and tolerability of elbasvir/grazoprevir (EBR/GZR) for East-Asian hepatitis C virus genotype 1b (HCV GT1b) patients receiving hemodialysis were limited. We prospectively recruited 40 HCV GT1b hemodialysis patients who received EBR/GZR for 12 weeks at 6 academic centers in Taiwan. The efficacy endpoints were sustained virologic response 12 weeks off-therapy (SVR12) by intention-to-treat (ITT) modified ITT (mITT) analyses. Patients' baseline characteristics, early viral kinetics and HCV resistance-associated substitutions (RASs) at HCV non-structural 3 and 5 A (NS3 and NS5A) regions potentially affecting SVR12 were analyzed. The tolerability for EBR/GZR was also assessed. The SVR12 rates by ITT and mITT analyses were 95% (38 of 40 patients; 95% confidence interval (CI): 83.5-98.6%) and 100% (38 of 38 patients; 95% CI: 90.8-100%), respectively. Patients' baseline characteristics, on-treatment viral decline, and baseline HCV RASs did not affect SVR12. All patients tolerated treatment well. Among 5 patients who had serious adverse events (AEs) including one death due to on-treatment suicide and the other death due to off-therapy acute myocardial infarction, none of these events were judged related to EBR/...Continue Reading

References

Jul 3, 2002·Annals of Internal Medicine·Daniele PratiGirolamo Sirchia
Dec 20, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·David W JohnsonJiaqi Qian
Jan 26, 2011·Journal of Gastroenterology and Hepatology·Chen-Hua Liu, Jia-Horng Kao
Mar 12, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Chen-Hua LiuJia-Horng Kao
Nov 7, 2013·American Journal of Nephrology·David A GoodkinMichel Jadoul
Apr 15, 2014·The New England Journal of Medicine·Fred PoordadBarry Bernstein
Apr 21, 2016·Journal of the American Society of Nephrology : JASN·Marco LadinoDavid Roth
Apr 4, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tai-Shuan LaiUNKNOWN REVEAL-HCV Study Group
Jan 27, 2018·The Lancet. Gastroenterology & Hepatology·Marcus M MückeJohannes Vermehren
Oct 10, 2018·Antiviral Research·Eiichi OgawaUNKNOWN Kyushu University Liver Disease Study (KULDS) Group
Nov 21, 2018·Nature Reviews. Nephrology·Stanislas PolMichel Jadoul
Jan 27, 2019·European Journal of Clinical Pharmacology·Luzelena CaroWendy W Yeh
May 18, 2019·JAMA : the Journal of the American Medical Association·Kristen Marks, Susanna Naggie

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception

Clinical Trials Mentioned

NCT03420300

Software Mentioned

HEP Drug Interaction Checker
Statistical Program for Social Sciences ( SPSS Statistics

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.